Umbilical Cord-Derived Mesenchymal Stem Cells for Hematopoietic Stem Cell Transplantation

被引：26

作者：

Chao, Yu-Hua ^{[2
,3
]}

Wu, Han-Ping ^{[4
]}

Chan, Chin-Kan ^{[5
]}

Tsai, Chris ^{[6
]}

Peng, Ching-Tien ^{[1
,7
,8
]}

Wu, Kang-Hsi ^{[1
,8
]}

机构：

[1] China Med Univ, Sch Chinese Med, Taichung, Taiwan

[2] Chung Shan Med Univ Hosp, Dept Pediat, Taichung, Taiwan

[3] Chung Shan Med Univ, Sch Med, Taichung, Taiwan

[4] Buddhist Tzu Chi Gen Hosp, Taichung Branch, Dept Pediat, Taichung, Taiwan

[5] Taoyuan Gen Hosp, Dept Pediat, Tao Yuan, Taiwan

[6] Bionet Corp, Taipei, Taiwan

[7] Asia Univ, Dept Biotechnol & Bioinformat, Taichung, Taiwan

[8] China Med Univ Hosp, Dept Pediat, Taichung, Taiwan

来源：

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY | 2012年

关键词：

HUMAN BONE-MARROW; VERSUS-HOST-DISEASE; EX-VIVO EXPANSION; STROMAL CELLS; ENHANCE ENGRAFTMENT; PERIPHERAL-BLOOD; PROGENITOR CELLS; FETAL BLOOD; COTRANSPLANTATION; CULTURE;

D O I：

10.1155/2012/759503

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

Hematopoietic stem cell transplantation (HSCT) is becoming an effective therapeutic modality for a variety of diseases. Mesenchymal stem cells (MSCs) can be used to enhance hematopoietic engraftment, accelerate lymphocyte recovery, reduce the risk of graft failure, prevent and treat graft-versus-host disease, and repair tissue damage in patients receiving HSCT. Till now, most MSCs for human clinical application have been derived from bone marrow. However, acquiring bone-marrow-derived MSCs involves an invasive procedure. Umbilical cord is rich with MSCs. Compared to bone-marrow-derived MSCs, umbilical cord-derived MSCs (UCMSCs) are easier to obtain without harm to the donor and can proliferate faster. No severe adverse effects were noted in our previous clinical application of UCMSCs in HSCT. Accordingly, application of UCMSCs in humans appears to be feasible and safe. Further studies are warranted.

引用

页数：5

共 54 条

[1]

Human mesenchymal stem cells modulate allogeneic immune cell responses [J].

Aggarwal, S ;

Pittenger, MF .

BLOOD, 2005, 105 (04) :1815-1822

[2]

Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero [J].

Almeida-Porada, G ;

Flake, AW ;

Glimp, HA ;

Zanjani, ED .

EXPERIMENTAL HEMATOLOGY, 1999, 27 (10) :1569-1575

[3]

Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation [J].

Almeida-Porada, G ;

Porada, CD ;

Tran, N ;

Zanjani, ED .

BLOOD, 2000, 95 (11) :3620-3627

[4]

Anker PSI, 2003, HAEMATOLOGICA, V88, P845

[5]

Failure of adult marrow-derived stem cells to generate marrow stroma after successful hematopoietic stem cell transplantation [J].

Awaya, N ;

Rupert, K ;

Bryant, E ;

Torok-Storb, B .

EXPERIMENTAL HEMATOLOGY, 2002, 30 (08) :937-942

[6]

T-cell suppression mediated by mesenchymal stem cells is deficient in patients with severe aplastic anemia [J].

Bacigalupo, A ;

Valle, M ;

Podestà, M ;

Pitto, A ;

Zocchi, E ;

De Flora, A ;

Pozzi, S ;

Luchetti, S ;

Frassoni, F ;

Van Lint, MT ;

Piaggio, G .

EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) :819-827

[7]

Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow [J].

Baksh, Dolores ;

Yao, Raphael ;

Tuan, Rocky S. .

STEM CELLS, 2007, 25 (06) :1384-1392

[8]

Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation [J].

Ball, Lynne M. ;

Bernardo, Maria Ester ;

Roelofs, Helene ;

Lankester, Arjan ;

Cometa, Angela ;

Egeler, R. Maarten ;

Locatelli, Franco ;

Fibbe, Willem E. .

BLOOD, 2007, 110 (07) :2764-2767

[9]

Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy [J].

Banfi, A ;

Muraglia, A ;

Dozin, B ;

Mastrogiacomo, M ;

Cancedda, R ;

Quarto, R .

EXPERIMENTAL HEMATOLOGY, 2000, 28 (06) :707-715

[10]

Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo [J].

Bartholomew, A ;

Sturgeon, C ;

Siatskas, M ;

Ferrer, K ;

McIntosh, K ;

Patil, S ;

Hardy, W ;

Devine, S ;

Ucker, D ;

Deans, R ;

Moseley, A ;

Hoffman, R .

EXPERIMENTAL HEMATOLOGY, 2002, 30 (01) :42-48

← 1 2 3 4 5 6 →